The results testify to the fact that CO2 is a powerful inhibitor of reactive oxygen species (ROS) generation by cells (blood phagocytes and alveolar macrophages of 96 people and cells of inner organs and tissue phagocytes (of liver, brain, myocardium, lungs, kidneys, stomach, and skeleton muscles), as well as by mitochondria of the liver of 186 white mice and human tissues. Generation of ROS was determined using various methods with CO2 directly acting on the cells and bioptates and indirectly on the organism as a whole. CO2 in the concentration of 5.1% (P = 37.5 mmHg), 8.2% (P = 60.0 mmHg), and 20% (P = 146.0 mmHg) in a mixture with air (total pressure = 730 mmHg) inhibits the basal ROS generation by phagocytes on the average by 3.52, 5.69, and 10.03 times, respectively (p < 0.05), and the stimulated by corpuscular particles: (a) zymosan by 3.24, 4.43, and 7.95 times; (b)SiO2: by 2.99, 3.24, and 5.76 times (p < 0.05). This is confirmed by the feet that CO2, along with inhibiting the O2 (-) generation by cells of the various organs, including the liver, as a rule, by 2.19-4.7 times, p < 0.01 or <0.001 induces simultaneously a decrease in the O2 (-) generation by mitochondria isolated from the liver (by 1.91-3.2 times, p < 0.001). The mechanism of CO2 influence is realized, in part, by inhibition of NADPH-oxidase activity. Taken into consideration proven role of CO2 in different pathophysiological conditions, (such as endoarteritis, bronchial asthma, and infectious diseases), present findings may be of clinical interest in terms of potential implementation of CO2 donors as adjuvant therapeutics in these diseases.

At the end of 2019, a new coronavirus infection occurred in the People’s Republic of China with an epicentre in the city of Wuhan. On February 11th, 2020, the World Health Organization assigned the official name of the infection caused by the new coronavirus – COVID-19. COVID-19 has affected people from all over the world given that the infection was noted in 200 countries resulting in annunciation of the pandemic situation. Human corona viruses cause mild to moderate respiratory infections. At the end of 2002, a new coronavirus appeared (SARS-CoV), the causal agent of atypical pneumonia, which caused acute respiratory distress syndrome (ARDS). The initial stage of COVID-19 infection is the penetration of SARS-CoV-2 into target cells that have angiotensin converting enzyme type II receptors. The virus enters the body through the respiratory tract and interacts primarily with toll-like receptors (TLRs). The events in SARS-Cov-2 induced infection follow the next scenario: epithelial cells via TLRs recognize and identify SARS-Cov-2, and after that the information is transmitted to the transcriptional NF-κB, which causes expression of the corresponding genes. Activated in this way, the epithelial cells begin to synthesize various biologically active molecules. The results obtained on preclinical material indicate that ROS generation increases and the antioxidant protection decreases, which plays a major role in the pathogenesis of SARS-CoV, as well as in the progression and severity of this respiratory disease.

This review summarizes the data regarding the gas transport characteristics of hemocorrection and perfusates on the basis of low concentrated drugs nano-sized perfluorocarbonic 20% Perftoran (a blood substitute, it is allowed for clinical use in Russia), 20% Ftoremulsion III (an improved blood substitute, registered in Russia), 10-20% Perfusol (a perfusion solution for perfusion of the isolated heart), 20% Ftorem (a cardioplegic emulsion for surgeries on the stopped heart) used in the biomedical field. The compensation of blood loss using traditional plasma substitutes without the gas transport function or with low gas transport characteristics leads to a decrease in the oxygen capacity of the resulting mixture and subsequently to deterioration in the oxygen transport characteristics of blood. The synthetic gas-transport blood substitutes can be used in the treatment of various forms of ischemia, such as carbon monoxide poisoning. Furthermore, recent results regarding the mechanism of COVID19 infection indicate a possible use of the synthetic gas-transport blood substitutes in the treatment and therapy of COVID19 infected patients.

The structure and properties of oil disperse systems (ODS) are mainly determined by the presence of paraffin hydrocarbons (n-alkanes) in the crude oil and natural gas liquid. Short-chain n-alkanes (С8-С17) are part of ODS dispersion medium. Under oil refining treatment, they concentrate in the distillate fractions and influence the operation characteristics of product liquid fuels and natural gas liquid.We studied the influence of hydrodynamic cavitation on the short-chain n-alkanes. Cavitation was produced by a high pressure disintegrator DA-1. A plunger pump produced compression pressure 50 MPa. Cavitation treatment was applied three times in a row. The research object was liquid oil paraffin containing 96.5% wt. n-alkanes С9-С21 (including 95% wt. С9-С17) and 2.5% wt. isoalkanes С10-С20; the balance was a mixture of other hydrocarbons. The results of GLC demonstrated that the total conversion of initial n-alkanes С14-С17 was not high, but it grew growing constantly: after the 1st cavitation cycle - 1.4%, after the 2nd cavitation cycle - 2.7%, after the 3rd one - 3.6%. At the highest conversion, the concentration of n-alkanes C8-C13 in liquid oil paraffin increased by 28% rel., and the concentration of n-alkanes C18-C22 - by 36% rel. The information obtained allows predicting the influence of the short-chain n-alkanes present in the oil feed on alterations of its hydrocarbon and fraction composition after cavitation.

The performance characteristics of a plane parallel chamber were investigated on beams of slow muons and positrons, as well as on an electron beam from a 106 Ru β source. The chamber was filled with ëé 2 or a gas mixture of Ar (30%) + CO 2 (70%) at atmospheric pressure. The amplitude spectra of charged particles and the efficiency of their detection were measured. The muon and positron momenta were ~27 MeV/ Ò . It was shown that the muon detection efficiency of the plane parallel chamber with a 1-mm gas gap and ëé 2 (100%) used as a working gas was as high as 99%, while that of the chamber with a 0.4-mm gas gap and a working gas mixture of Ar(30%) + CO 2 (70%) was 88%. This result, along with the detector's high response speed, allows the plane parallel chamber to be used as an active target being developed for a future experiment (FAMILON) on searching for neutrinoless muon decay with the release of a scalar Goldstone's boson ( µ e α ).